 |
|
|
|
|
Home
|
The new threat to your portfolio
|
|
May 21st, 2012
|
|
In the current pullback, we're starting to see a phenomenon at work that keeps even good stocks in retreat -- and invites investors to buy high and sell low.
|
|
What I don't 'like' about Facebook
|
|
May 21st, 2012
|
|
The IPO will be huge; the company has an impressive reach. But what does it say when our hottest business wins because young adults are stuck on couches?
|
|
Can the central banks keep us safe?
|
|
May 21st, 2012
|
|
The financial markets are holding their own these days, based on the idea the Fed and other central banks will save us from the worst. But what if they can't?
|
|
What to know about Facebook's IPO
|
|
May 21st, 2012
|
|
The company's rise is one of the great business stories of our time. But just how valuable is social media? We'll get an indication this week.
|
|
10 stocks for the bad old summertime
|
|
May 21st, 2012
|
|
The road ahead promises a lot of ups and downs, something we're starting to see already. A list can help you recognize and snap up bargain stocks.
|
|
What the 99% are getting right
|
|
May 21st, 2012
|
|
A global backlash is brewing as the masses revolt at rescues and bailouts for those at the top of the economic scale, and austerity for the rest.
|
|
Facebook's hot, but Google's cheap
|
|
May 21st, 2012
|
|
Yes, the search giant goes for $600 a share. But that price has fallen recently on several worries, including that Facebook will eat into Google's turf.
|
|
Markets don't fear a fiscal cliff
|
|
May 21st, 2012
|
|
The tax hikes and spending cuts scheduled to kick in at year's end could wreck the economy. So why isn't Wall Street sweating?
|
|
Featured Stories
|
|
|
Sick Investment Tools, Copyright © 2009-2011, Sick Investment Tools LLC. All rights reserved. The content of this site may not be redistributed without the express written consent of
Sick Investment Tools. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Sick Investment Tools as well as a link to www.sickinvestmenttools.com. Your privacy is important to us—we will never rent or sell your e-mail or personal information. Please read our Privacy Policy.
No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein.
Sick Investment Tools does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of
Sick Investment Tools may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.
|
|
|